Cite
HARVARD Citation
Ray, K. et al. (2018). Effect of an RNAi therapeutic targeting PCSK9 on atherogenic lipoproteins: Pre-specified secondary endpoints in orion 1. Atherosclerosis. pp. e9-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Ray, K. et al. (2018). Effect of an RNAi therapeutic targeting PCSK9 on atherogenic lipoproteins: Pre-specified secondary endpoints in orion 1. Atherosclerosis. pp. e9-. [Online].